How does 5UD's PS Ratio compare to its peers?

5UD is expensive based on its Price-To-Sales Ratio (3.7x) compared to the peer average (0.5x).

How does 5UD's PS Ratio compare vs other companies in the European Consumer Retailing Industry?

5UD is expensive based on its Price-To-Sales Ratio (3.7x) compared to the European Consumer Retailing industry average (0.4x).

What is 5UD's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate 5UD's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of 5UD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

5UD (€0.89) is trading above our estimate of [[fair value]] (€0.39)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

5UD Stock Overview

Provides online chronic disease management services in China. More details

5UD fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Rewards

Revenue grew by 6.4% over the past year

Risk Analysis

Negative shareholders equity

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Fangzhou Inc. Competitors

Redcare Pharmacy

XTRA:RDC

€2.8b

Metro

XTRA:B4B

€1.4b

HelloFresh

XTRA:HFG

€1.9b

Hawesko Holding

XTRA:HAW

€245.2m

Price History & Performance

Summary of share price highs, lows and changes for Fangzhou
Historical stock prices
Current Share Price	HK$0.85
52 Week High	HK$0.94
52 Week Low	HK$0.63
Beta	0
1 Month Change	25.11%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	18.14%

Recent updates

Shareholder Returns

	5UD	DE Consumer Retailing	DE Market
7D	17.0%	-5.1%	-2.0%
1Y	n/a	-15.1%	6.9%

Return vs Industry: Insufficient data to determine how 5UD performed against the German Consumer Retailing industry.

Return vs Market: Insufficient data to determine how 5UD performed against the German Market.

Price Volatility

Is 5UD's price volatile compared to industry and market?
5UD volatility
5UD Average Weekly Movement	n/a
Consumer Retailing Industry Average Movement	6.3%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.3%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 5UD's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 5UD's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2015	515	Fangmin Xie	Jianke.com

Fangzhou Inc. provides online chronic disease management services in China. The company provides services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory chronic diseases. It offers H2H services, including online medical consultation services, e-prescription, and prescription refill services through mobile application; and healthcare products through online retail pharmacy service platform, as well as operates hospitals and offline pharmacies.

Fangzhou Inc. Fundamentals Summary

How do Fangzhou's earnings and revenue compare to its market cap?
5UD fundamental statistics
Market cap	€1.17b
Earnings (TTM)	-€113.44m
Revenue (TTM)	€324.69m

3.6x

P/S Ratio

-10.3x

P/E Ratio

Is 5UD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
5UD income statement (TTM)
Revenue	CN¥2.47b
Cost of Revenue	CN¥1.96b
Gross Profit	CN¥505.95m
Other Expenses	CN¥1.37b
Earnings	-CN¥861.62m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.64
Gross Margin	20.52%
Net Profit Margin	-34.94%
Debt/Equity Ratio	-100.8%

How did 5UD perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 23:41
End of Day Share Price	2024/12/23 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fangzhou Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

Fangzhou DB:5UD Stock Report